SR

Stephen Russell

CEO

Vyriad

Rochester, Minnesota


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Vyriad
Industry
biotechnology
Employees
50.0
Seniority
C suite
Annual Revenue
2500000.0
Total Funding
54376966.0
Latest Funding
Series B

Technologies

Sendgrid Outlook WordPress.org reCAPTCHA Vimeo Mobile Friendly Google Tag Manager

Keywords

oncolytic virus gene therapy virotherapy viral delivery platform car-t therapy gene editing clinical trials vaccine development viral vector oncology immunotherapy pharmaceutical collaboration gmp manufacturing in vivo therapy targeted therapies viral engineering therapeutic development mayo clinic partnership serum-stability viral vectors cancer treatment clinical expertise preclinical development viral payloads pharma partnerships delivery solutions phase 1 trials gene transfer biopharmaceuticals therapeutic applications engineered viruses biotechnology innovation targeted medicine personalized medicine immune response clinical research viral-based therapies therapeutic protocols drug development leading medical institutions interdisciplinary teams cross-functional collaboration pandemic response covid-19 vaccines infectious disease therapy cancer immunotherapy vaccine-related research health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans